Intrathecal treatment for spasticity

Stereotactic and Functional Neurosurgery

Volumn 76, Issue 3-4, 2001, Pages 246-248

  Miles, John ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Baclofen; Intrathecal; Spasticity

Indexed keywords

BACLOFEN; SPASMOLYTIC AGENT;

CEREBRAL PALSY; CONFERENCE PAPER; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HUMAN; INJURY; MULTIPLE SCLEROSIS; SIDE EFFECT; SPASTICITY; SPINAL CORD;

DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS, SPINAL; MUSCLE SPASTICITY; PARASYMPATHOLYTICS;

EID: 0035788731     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066726     Document Type: Conference Paper

References (6)

1. Penn RD, Kroin JS: Intrathecal baclofen alleviates spinal cord spasticicty. Lancet 1984;i:1078.
2. Penn RD: Intrathecal baclofen for spasticity of spinal cord origin: seven years of experience. J Neurosurg 1992;77:236-240.
3. Ordia JI, Fischer E, Adamski E, Spatz EL: Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996;85:452-457.
4. Dralle D, Muller H, Zierski J, Klug N: Intrathecal baclofen for spasticity. Lancet 1985;ii:1003.
5. Allbright AL, Cervi A, Singletary J: Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-1422.
6. Meythaller JM, DeVivo MJ, Hadley M: Prospective study on the use of bolus intrathecal baclofen for spasticity hypertonia due to acquired brain injury. Arch Phys Med Rehab 1996;7:461-466.